Vanda Pharmaceuticals Inc. (VNDA)

CIK 1347178 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Vanda Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Aug 19, 2026SCHEDULE 13G0001104659-26-098866
Aug 13, 2026SCHEDULE 13G0001167557-26-000170
Aug 6, 202610-Q0001628280-26-053855
Aug 5, 20268-K0001628280-26-053308
Jun 8, 202640001193125-26-261806
Jun 8, 202640001193125-26-261871
Jun 8, 202640001193125-26-261768
Jun 8, 202640001193125-26-261790
Jun 8, 202640001193125-26-261811
Jun 8, 202630001193125-26-261752
Jun 8, 202640001193125-26-261782
Jun 8, 202640001193125-26-261800
Jun 5, 20268-K0001628280-26-041298
Jun 5, 2026S-80001628280-26-041303
May 20, 202640001802653-26-000003
May 12, 2026SCHEDULE 13G0000093751-26-000309
May 7, 202610-Q0001628280-26-031667
May 6, 20268-K0001628280-26-031241
May 5, 2026EFFECT9999999995-26-001496
Apr 29, 2026SCHEDULE 13G/A0002052113-26-000465
Apr 24, 202630002130896-26-000006
Apr 24, 202640002130896-26-000008
Apr 23, 2026DEFA14A0001628280-26-026896
Apr 23, 2026ARS0001628280-26-026899
Apr 23, 2026DEF 14A0001628280-26-026893